More about

Docosahexaenoic Acid

Clinical Guidance
Lipid Management
Treatment Approaches

Omega-3 Fatty Acids

Jennifer G. Robinson, MD, MPH

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News
August 02, 2023
3 min read
Save

Consuming more omega-3 fatty acids preserves lung function in healthy adults

Consuming more omega-3 fatty acids preserves lung function in healthy adults

In healthy adults, higher levels of omega-3 fatty acids promoted lung health by lowering the rate of yearly lung function decline, according to results published in American Journal of Respiratory and Critical Care Medicine.

News
July 24, 2023
2 min read
Save

Consuming more omega-3 fatty acids may help prevent hearing loss

Consuming more omega-3 fatty acids may help prevent hearing loss

Higher blood levels of the omega-3 fatty acid docosahexaenoic acid may help protect against hearing loss, according to the results of research presented at NUTRITION.

News
July 26, 2021
1 min read
Save

Top in cardiology: EPA monotherapy, ambulatory BP

Top in cardiology: EPA monotherapy, ambulatory BP

A new meta-analysis discussed how eicosapentaenoic acid monotherapy, compared with eicosapentaenoic acid plus docosahexaenoic acid, provided the greatest reduction in cardiovascular risk.

News
July 22, 2021
1 min read
Save

In omega-3 fatty acid trials, EPA alone yields greater CV risk reduction vs. EPA plus DHA

In omega-3 fatty acid trials, EPA alone yields greater CV risk reduction vs. EPA plus DHA

In a meta-analysis of omega-3 fatty acid trials, eicosapentaenoic acid monotherapy yielded the greatest reduction in CV risk vs. a combination of eicosapentaenoic acid and docosahexaenoic acid.

News
May 21, 2021
2 min read
Save

Higher DHA levels reduce protective impact of EPA on major adverse CV events

Higher DHA levels reduce protective impact of EPA on major adverse CV events

Higher levels of eicosapentaenoic acid were associated with reductions in major adverse events, in particular improved survival, according to a presentation at the American College of Cardiology Scientific Session.

News
October 02, 2020
2 min read
Save

Omega-3 fatty acid supplementation may reduce risk for certain CVD outcomes

Omega-3 fatty acid supplementation may reduce risk for certain CVD outcomes

Supplementation with eicosapentaenoic acid and docosahexaenoic acid may reduce the risk for some CVD outcomes, including fatal MI and CHD events, researchers found.

News
July 17, 2020
1 min read
Save

Maternal docosahexaenoic acid fails to improve bronchopulmonary dysplasia survival

Maternal docosahexaenoic acid fails to improve bronchopulmonary dysplasia survival

Maternal docosahexaenoic acid supplementation did not improve bronchopulmonary dysplasia-free survival in breastfed preterm infants compared with placebo, according to results of a randomized clinical trial published in JAMA Network Open.